Lilly researchers say FDA was consistent in meeting its mid-cycle communication goals under a 2012 program to educate regulatory professionals about t...
FDA approves an emergency use authorization for InflaRxs Gohibic to treat some hospitalized Covid-19 patients.
FDA clears a BC3 Technologies 510(k) for its SEAL Hemostatic Wound Spray.
FDA says it is requiring opioid analgesic manufacturers to make prepaid mail-back envelopes available to outpatient pharmacies and other dispensers as...
CBERs Office of Compliance and Biologics Quality sends an untitled letter to Minneapolis Regenerative Medicine over claims made on the firms Web site....
FDA grants a de novo marketing authorization to Happiest Baby for its SNOO, a medical device for keeping sleeping babies safely on their backs.
Federal Register notice: FDA makes available a draft guidance entitled Infectious Otitis Externa Drugs for Topical Use in Dogs.
FDA finds deficiencies in Ascendis Pharmas NDA for TransCon PTH (palopegteriparatide), indicated for treating hypoparathyroidism.
